Quiescent Hepatic Stellate Cells Functionally Contribute to the Hepatic Innate Immune Response via TLR3
Open accessThe DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Abstract
Toll-like Receptor 3 (TLR3) is a pathogen pattern recognition receptor that plays a key role in innate immunity. TLR3 signalling has numerous functions in liver, both in health and disease. Here we report that TLR3 is expressed by quiescent hepatic stellate cells (HSC) where it functions to induce transcription and secretion of functional interferons as well as a number of other cytokines and chemokines. Upon transdifferentiation into myofibroblasts, HSCs rapidly loose the ability to produce interferon gamma (IFNγ). Mechanistically, this gene silencing may be due to Polycomb complex mediated repression via methylation of histone H3 lysine 27. In contrast to wild type, quiescent HSC isolated from tlr3 knockout mice do not produce IFNγ in response to Poly(I∶C) treatment. Therefore, quiescent HSC may contribute to induction of the hepatic innate immune system in response to injury or infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“TLR3 stimulation by double stranded RNA in qHSCs prompts IFNγ production (29).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [29]
In the citing paper
“Quiescent HSCs (qHSCs) are primed by expression of multiple pattern recognition receptors (PRRs), including TLRs 3 and 4 (29).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304 · cited 1×
“The molecular triggers for innate immunity are pattern recognition receptors (PRRs) [5] including the IL-1 Receptors [6] (reviewed in [7]), members of the Toll-like Receptor (TLR) family [8] and Nucleotide Oligomerisation Domain (NOD)-like receptor families [9].”
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
Toll-like receptors in the induction of the innate immune response
Aderem, A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,064 · cited 1×
“Upon engagement by their ligands, the TLRs trigger a cascade of intracellular signalling pathways that culminate in induction of genes encoding interferons, cytokines and chemokines required for the recruitment and activation of innate immune cells [10].”
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842 · cited 2×
“However, in the chronically injured liver, this normal physiological process may become dysregulated and lead to the development of fibrosis [1].”
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,634
Ozinsky, A., Underhill, D. M., Fontenot, J. D., Hajjar, A. M., Smith, K. D., Wilson, C. B., Schroeder, L., & Aderem, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250476497 · Cited by 2,085 · cited 1×
“The molecular triggers for innate immunity are pattern recognition receptors (PRRs) [5] including the IL-1 Receptors [6] (reviewed in [7]), members of the Toll-like Receptor (TLR) family [8] and Nucleotide Oligomerisation Domain (NOD)-like receptor families [9].”
Self-citationTLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942 · cited 2×
“Seki et al, have described how TLR4 on activated mouse HSC is required for sensitising the cells to TGFb1, specifically by promoting down-regulation of the TGFb1 pseudo-receptor Bambi [13].”
BackgroundInnate immune recognition of viral infection
Kawai, T., & Akira, S. (2006) · Nature Immunology · doi:10.1038/ni1303 · Cited by 1,899 · cited 1×
“TLR3 plays a fundamental anti-viral role by producing interferons (IFN) in response to viral dsRNA [19].”
MyD88 Is an Adaptor Protein in the hToll/IL-1 Receptor Family Signaling Pathways
Medzhitov, R., Preston-Hurlburt, P., Kopp, E., Stadlen, A., Chen, C., Ghosh, S., & Janeway, C. A. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80136-7 · Cited by 1,575 · cited 1×
“The molecular triggers for innate immunity are pattern recognition receptors (PRRs) [5] including the IL-1 Receptors [6] (reviewed in [7]), members of the Toll-like Receptor (TLR) family [8] and Nucleotide Oligomerisation Domain (NOD)-like receptor families [9].”
Gordon, S. (2002) · Cell · doi:10.1016/s0092-8674(02)01201-1 · Cited by 1,155 · cited 1×
“The molecular triggers for innate immunity are pattern recognition receptors (PRRs) [5] including the IL-1 Receptors [6] (reviewed in [7]), members of the Toll-like Receptor (TLR) family [8] and Nucleotide Oligomerisation Domain (NOD)-like receptor families [9].”
Cited by
Weiskirchen, R., & Tacke, F. (2014) · PubMed · doi:10.3978/j.issn.2304-3881.2014.11.03 · Cited by 256
“This assumption was recently impressively underpinned by Wilson and coworkers who showed that quiescent HSC isolated from tlr3 deficient mice do not produce IFN-γ in response to treatment with the TLR3 agonist polyI:polyC (74).”
BackgroundSeo, W., Eun, H. S., Kim, S. Y., Yi, H., Lee, Y., Park, S., Jang, M., Jo, E., Kim, S. C., Han, Y., et al. (2016) · Hepatology · doi:10.1002/hep.28644 · Cited by 175
“Along with previous reports and present data,((27,30)) D1 qHSCs treated with poly I:C increased expression of IL-17A, IL-10, and IFN-c, whereas D1 qHSCs treated with exosomes did not increase expression of IFN-c (Supporting Fig.”
BackgroundResultInfluentialZisser, A., Ipsen, D. H., & Tveden-Nyborg, P. (2021) · Biomedicines · doi:10.3390/biomedicines9040365 · Cited by 104
“qHSCs are thought to contribute to ECM homeostasis, hepatocyte proliferation, innate immunity, and sinusoidal blood flow regulation [22,23].”
BackgroundToll-like receptors and metabolic (dysfunction)-associated fatty liver disease
Khanmohammadi, S., & Kuchay, M. S. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106507 · Cited by 108
Baghaei, K., Mazhari, S., Tokhanbigli, S., Parsamanesh, G., Alavifard, H., Schaafsma, D., & Ghavami, S. (2021) · World Journal of Gastroenterology · doi:10.1016/j.drudis.2021.12.012 · Cited by 93
Nyúl‐Tóth, Á., Kozma, M., Nagyőszi, P., Nagy, K. S., Fazakas, C., Haskó, J., Molnár, K., Farkas, A. E., Végh, A. G., Váró, G., et al. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.04.010 · Cited by 84
Hepatic Stellate Cell-Immune Interactions in NASH
Carter, J. K., & Friedman, S. L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.867940 · Cited by 79
“TLR3 stimulation by double stranded RNA in qHSCs prompts IFNg production (29).”
BackgroundHassan, R., Tammam, S. N., Elsafy, S., Abdel‐Halim, M., Asimakopoulou, A., Weiskirchen, R., & Mansour, S. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.11.018 · Cited by 69
The cellular pathways of liver fibrosis in non-alcoholic steatohepatitis
Méndez‐Sánchez, N., Valencia-Rodríguez, A., Coronel-Castillo, C. E., Vera-Barajas, A., Contreras-Carmona, J., Ponciano‐Rodríguez, G., & Zamora‐Valdés, D. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.184 · Cited by 57
“Wilson CL, Mann J, Walsh M, et al. Quiescent Hepatic Stellate Cells Functionally Contribute to the Hepatic Innate Immune Response via TLR3.”
BackgroundPaish, H. L., Kalson, N. S., Smith, G. R., del Carpio Pons, A., Baldock, T. E., Smith, N., Swist-Szulik, K., Weir, D. J., Bardgett, M., Deehan, D. J., et al. (2018) · The American Journal of Pathology · doi:10.1016/j.ajpath.2017.11.007 · Cited by 44
Self-citationLuo, J., Liang, Y., Kong, F., Qiu, J., Liu, X., Chen, A., Luxon, B. A., Wu, H. W., & Wang, Y. (2016) · Immunology and Cell Biology · doi:10.1038/icb.2016.109 · Cited by 41
Nanodrug delivery: Strategies to circumvent nanoparticle trafficking by Kupffer cells in the liver
Ezhilarasan, D., & Harini, K. S. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104731 · Cited by 42
Association of Toll-Like Receptor 3 Single-Nucleotide Polymorphisms and Hepatitis C Virus Infection
Al‐Anazi, M. R., Matou‐Nasri, S., Abdo, A. A., Sanai, F. M., Alkahtani, S. H., Alarifi, S. A., Alkahtane, A. A., Al‐Yahya, H., Ali, D., Alessia, M. S., et al. (2017) · Journal of Immunology Research · doi:10.1155/2017/1590653 · Cited by 33
Khoso, P. A., Yang, Z., Liu, C., & Li, S. (2015) · Cell Stress and Chaperones · doi:10.1007/s12192-015-0625-9 · Cited by 30
“Previous studies have shown that Se deficiency inhibits the proliferation of T and B lymphocytes (Wilson et al. 2014).”
You, L., Liu, C., Yang, Z., Li, M., & Li, S. (2014) · Biological Trace Element Research · doi:10.1007/s12011-014-0049-x · Cited by 28
Kendall, T. J., Duff, C. M., Boulter, L., Wilson, D. H., Freyer, E., Aitken, S., Forbes, S. J., Iredale, J. P., & Hastie, N. D. (2019) · Nature Communications · doi:10.1038/s41467-019-12701-9 · Cited by 27
Tee, J. K., Peng, F., Tan, Y. L., Yu, B., & Ho, H. K. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01018 · Cited by 27
“function as vitamin-A storing cells which maintain the normal basement membrane matrix and mediate the hepatic innate immune system (Weiskirchen and Tacke, 2014; Wilson et al., 2014).”
BackgroundInterorgan communication with the liver: novel mechanisms and therapeutic targets
Zhao, J., Zhang, X., Li, Y., Yu, J., Chen, Z., Niu, Y., Ran, S., Wang, S., Ye, W., Luo, Z., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1314123 · Cited by 32
Decoding liver injury: A regulatory role for histone modifications
Tian, W., & Xu, Y. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.03.009 · Cited by 18
TLR3 Activation of Hepatic Stellate Cell Line Suppresses HBV Replication in HepG2 Cells
Zhang, B., Liu, Y., Wang, X., Li, J., Xu, X.-Q., Guo, L., & Ho, W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02921 · Cited by 19
“The activated HSCs produce fibril-forming collagens and promote net deposition of fibrotic extracellular matrix to repair liver injury (21).”
BackgroundStöß, C., Laschinger, M., Wang, B., Lu, M., Altmayr, F., Hartmann, D., Hüser, N., & Holzmann, B. (2020) · The FASEB Journal · doi:10.1096/fj.202000904r · Cited by 14
Pharmacological manipulation of liver fibrosis progression using novel HDAC 6 inhibitors
Borrello, M. T., Ružić, D., Paish, H. L., Graham, E., Collins, A., Scott, R., Higginbotham, S., Radović, B., Nelson, G., Bulmer, D. M., et al. (2025) · FEBS Journal · doi:10.1111/febs.70062 · Cited by 9
“3A, freshly isolated HSC were prepared and subsequently cultured in full-serum supplemented media on plastic for 4 days to adopt an activated phenotype [37,38].”
Self-citationTherapeutic Impact of ODN2088 to Block TLR9 Activity in Induced Liver Fibrosis Mice
Alzahrani, B., Alame, A. A. M., & Tantawy, A. (2021) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2021.122.131 · Cited by 4
Intrahepatic regulation of antiviral T cell responses at initial stages of viral infection
Liang, Y., Kwota, Z., & Sun, J. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.07.021 · Cited by 5
“Quiescent HSCs express TLR3 and respond to viral nucleic acids, such as Poly I:C [35].”
BackgroundCaligiuri, A., & Marra, F. (2015) · Wiley eBooks · doi:10.1002/9781118663387.ch3 · Cited by 2
Xiao, X., Xiang, R., Liu, J., Guo, Z., Liu, H., Lin, X., Bao, M., Viscardi, A., & Han, J. (2025) · Immunologic Research · doi:10.1007/s12026-025-09650-5 · Cited by 2
“Notably, the spleen is relatively sensitive to Se supply, yet Se deficiency can affect normal immune function by inhibiting the proliferation of T lymphocytes and B lymphocytes[4].”
Seo, W., Jo, E., & Jeong, W. (2016) · Hepatology · doi:10.1002/hep.28728
“Quiescent HSCs can express TLR3, and its activation may contribute to protection against infection and alcoholic liver injury by producing several cytokines.((3,4)) In natural killer (NK) cells, poly I:C-mediated TLR3 activation attenuates liver fibrosis by killing HSCs.”
BackgroundStem Cell Therapy Delivery in Liver Disease
Langford, J. T., & Tietjen, G. T. (2020) · Springer eBooks · doi:10.1007/978-3-030-56954-9_18
Melo, L., Hagar, A., & Klaunig, J. E. (2021) · Comparative Exercise Physiology · doi:10.3920/cep210033
Epigenetic drug control of Clec4g/LSECtin expression reduces fibrosis burden in cirrhosis
Ángel‐Gomis, E., Gómez‐Hurtado, I., Fernández-Barrena, M. G., Juanola, O., Martínez‐López, S., Boix, P., Ávila, M. A., Caparrós, E., & Francés, R. (2026) · Hepatology Communications · doi:10.1097/hc9.0000000000000961
“[14] In addition, the regulation of crucial inflammatory genes by epigenetic mechanisms has been demonstrated in chronic liver disease and HCC, [15,16] and has been linked to the adaptive immunity imbalance; [17] however, specific mechanisms controlling LSECs' C-type lectin receptors in cirrhosis…”
Wu, H., 王天宝, Yang, F., Yue, M., Li, A., & Si, C. (2026) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-026-10120-2
“Studies demonstrate that TLR3 activation can modulate HSC activation states, transdifferentiation, and pro-fibrotic phenotype (Byun et al. 2013 ; Wilson et al. 2014).”
Metadata
- Authors
- Wilson, C. L., Mann, J., Walsh, M., Perrugoria, M. J., Oakley, F., Wright, M. C., Brignole, C., Di Paolo, D., Perri, P., Ponzoni, M., Karin, M., & Mann, D. A.
- Affiliations
- Newcastle University (GB)
- Istituto Giannina Gaslini (IT)
- University of California San Diego (US)
- Corresponding author
- Mann, Derek A.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-01-08
- Volume
- 9
- Issue
- 1
- Pages
- e83391
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3885413
- OpenAlex
- W2004315368
- Cited by
- 31
- References
- 36
- Citations by year
- 2026: 2 · 2025: 2 · 2023: 2 · 2022: 2 · 2021: 4 · 2020: 3 · 2019: 1 · 2018: 3 · 2017: 3 · 2016: 4 · 2015: 3 · 2014: 2
- FWCI
- 1.83
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Newcastle University ePrints (Newcastle Univesity) (cc-by)
- Funders
- Wellcome Trust (WT086755MA)
- European Commission (223151)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- National Institutes of Health (P50AA11199)
- Medical Research Council (MK/K001949/1, G0700890, MR/K001949/1)
- NIHR Newcastle Biomedical Research Centre
- National Institute on Alcohol Abuse and Alcoholism (R24 AA12885, P50AA11199, U01AA018663, R24AA012885, P50AA011999)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- hepatic stellate cells, TLR3, hepatic innate immunity, interferon-gamma, interferon secretion, cytokine and chemokine production, myofibroblast transdifferentiation, Polycomb complexes, histone H3 lysine 27 methylation, poly(I:C), liver injury, liver infection
- MeSH terms
- Animals, Cell Cycle, Immunity, Innate, Interferons, Ligands, Liver, Transcription, Genetic, Cytokines, Rats, Sprague-Dawley, Mice, Knockout, Toll-Like Receptor 3, Mice, Hepatic Stellate Cells, Polycomb-Group Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.